Alexander J. Lazar

Dr. Alexander J. Lazar holds multiple professorial appointments at The University of Texas MD Anderson Cancer Center:

• Primary: Department of Pathology, Division of Pathology/Lab Medicine
• Department of Genomic Medicine, Division of Basic Science Research
• Department of Translational Molecular Pathology
• Department of Dermatology, Division of Internal Medicine
• Graduate School of Biomedical Sciences (Genetics/Immunology)
• Adjunct Professor, School of Health Professions

As an academic surgical pathologist specializing in sarcoma and melanoma, his research centers on molecular diagnostics and tissue-based translational studies. He leads clinical next-generation sequencing strategy implementation and co-investigates multiple translational projects through the Multidisciplinary Translational Sarcoma Lab.

Dr. Lazar significantly influences national cancer standards through committee representation:

• American Joint Committee on Cancer (AJCC)
• College of American Pathologists (CAP)
• Centers for Disease Control (CDC)
• Connective Tissue Oncology Society (CTOS)
• National Institutes of Health (NIH)
• The Cancer Genome Atlas (TCGA)
• US/Canadian Academy of Pathology (USCAP)

His clinical trial work focuses on melanoma molecular stratification, while his lab drives sarcoma biomarker discovery through integrated genomic-pathologic analysis.